Brainlab unveils ExacTrac Dynamic® TrueBeam system Novalis Bravos

Radio Therapy

Founded in 1972, Israel Scientific Instruments Ltd. is Israel’s foremost supplier of medical radiotherapy equipment, holding ~80% of the local market.

In its capacity as the exclusive representative of Varian Medical Systems in Israel, ISI has supplied Varian medical linear accelerators and related equipment to the following major oncology and radiotherapy institutes:

 

Read more »

Latest News & Products

  • ISCORT 2019 Conference & Exhibition

    Visit us at the Israeli Society for Clinical Oncology and Radiation Therapy - ISCORT 2019 Conference & Exhibition - Booth 24, January 8-11, 2019 at the Dan Hotel, Eilat

  • Mr. Moshe Stiener recieved Varian's "Lifetime Achievement Award"

    Budapest, Nov-2018 -- Mr. Moshe Steiner, Founder and President of ISI, received at VARIAN's annual Distributors & Sales Summit, a special VARIAN Lifetime Achievement Award after 45 years of exceptionally successful activity as the exclusive distributor of VARIAN in ISRAEL.

  • Next Generation ExacTrac Broadens Clinical Workflows

    MUNICH, Sunday, October 21, 2018 — Brainlab unveils ExacTrac Dynamic® at the American Society for Radiation Oncology (ASTRO) meeting in San Antonio, Texas. This forward-thinking universal concept for radiotherapy patient positioning and monitoring offers value on multiple fronts, including expanded clinical indications, broad technological advancements, enhanced user and patient experience, and technology consolidation. ExacTrac Dynamic is the next generation of ExacTrac X-Ray, a clinically proven positioning and monitoring solution for radiotherapy treatments. Since its release in 1999, ExacTrac systems have been used in more than one million treatments worldwide.

  • Varian Unveils New Bravos Afterloader System for Brachytherapy Treatments

    PALO ALTO, Calif., Oct. 21, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced the Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy treatments. Based on over five years of in-clinic research, Bravos is an integrated system designed to improve the patient and clinic experience by simplifying brachytherapy treatment and providing greater workflow efficiency. Bravos integrates with Varian's BrachyVision™ for treatment planning and offers interoperability with Varian ARIA® oncology information system. Bravos has received CE mark and FDA 510(k) clearance.

  • ARIA NAMED 2018 “BEST IN KLAS” CATEGORY LEADER

    The ARIA® oncology information system (OIS) version 15.5 was recently named a Category Leader in the 2018 Best in KLAS: Software and Services Report by KLAS, an independent research firm specializing in monitoring and reporting on the performance of healthcare vendors.

  • Brainlab Announces Interoperability of ExacTrac and Varian’s Edge® System

    MUNICH, April 3, 2018 – Today Brainlab announced an agreement with Varian to address interoperability of Brainlab ExacTrac® versions 5.x, 6.x and new product generations currently under development, with Varian’s Clinac® platform, TrueBeam™ and Edge® systems. To support and enhance the interoperability between the companies’ products, Brainlab and Varian will complete joint testing, verification and validation.

  • HALCYON

    The Halcyon™ system is Varian’s newest cancer treatment device, engineered to simplify and enhance virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT). Halcyon combines fast volumetric imaging and dose delivery with the power of Eclipse™ treatment planning system in a transformative platform.

  • TrueBeam Radiotherapy System

    TrueBeam system brings leading edge cancer care to communities by positioning clinics at the forefront in the fight against cancer. Designed from the ground up to treat moving targets with advanced speed and accuracy, the TrueBeam platform is a fully-integrated system for image-guided radiotherapy and radiosurgery.

  • Novalis

    Novalis Radiosurgery strengthens the strategic position of facilities dedicated to a comprehensive and focused vision for excellence in targeted cancer treatments.

  • PROBEAM 360° PROTON THERAPY SYSTEM

    Introducing the new ProBeam® 360° Proton Therapy System, designed for next-generation proton therapy. The ProBeam 360° System offers uncompromised clinical capabilities with ultra-high dose rates, a 360-degree gantry, and exceptional precision, all within a 30% smaller footprint.

Jump to page content